stage iva prostate cancer ajcc v8
Showing 26 - 43 of 43
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed
Not yet recruiting
- Metastatic Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Image Guided Biopsy
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jun 17, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate
Suspended
- Castration-Resistant Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- 68Ga-PSMA-11
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California San Francisco
Feb 27, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Salt Lake
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Atezolizumab
- Cabozantinib S-malate
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Mar 11, 2022
Biochemically Recurrent Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +6 more
- Computed Tomography
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 7, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial (Pharmacotherapy
Not yet recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Pharmacotherapy Discontinuation
- +3 more
- (no location specified)
Feb 11, 2022
Pharmacogenomics Testing in Directing Optimal Use of Supportive
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +45 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Feb 3, 2022
Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial
Recruiting
- Aggressive Variant Prostate Carcinoma
- +9 more
- Ipilimumab
- Valemetostat
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Bone Trial in
Recruiting
- Castration-Resistant Prostate Carcinoma
- +17 more
- Cryosurgery
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 29, 2021
Localized Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Jacksonville
Recruiting
- Localized Prostate Carcinoma
- +4 more
- Cholecalciferol
- Quality-of-Life Assessment
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 1, 2021
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Mexico, United
Recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone
- +14 more
-
Gilbert, Arizona
- +301 more
Nov 8, 2021
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Los Angeles
Completed
- Biochemically Recurrent Prostate Carcinoma
- +8 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 29, 2021
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +4 more
- Educational Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 13, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue
Withdrawn
- Castration Levels of Testosterone
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 31, 2021
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston
Withdrawn
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Apalutamide
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 14, 2021